FRANCISCO
MARTÍN MOLINA
CONTRATO MARÍA ZAMBRANO SENIOR
Publicaciones en las que colabora con KARIM BENABDELLAH EL KHLANJI (33)
2023
-
Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells
Molecular Therapy - Nucleic Acids, Vol. 32, pp. 322-339
-
Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDi
Molecular Therapy Nucleic Acids, Vol. 34
2022
-
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma
Frontiers in Immunology, Vol. 13
-
Erratum: Physiological lentiviral vectors for the generation of improved CAR-T cells (Molecular Therapy - Oncolytics (2022) 25 (335–349), (S2372770522000687), (10.1016/j.omto.2022.05.003))
Molecular Therapy - Oncolytics
-
Physiological lentiviral vectors for the generation of improved CAR-T cells
Molecular Therapy - Oncolytics, Vol. 25, pp. 335-349
2021
-
Baboon Envelope Pseudotyped “Nanoblades” Carrying Cas9/gRNA Complexes Allow Efficient Genome Editing in Human T, B, and CD34+ Cells and Knock-in of AAV6-Encoded Donor DNA in CD34+ Cells
Frontiers in Genome Editing, Vol. 3
-
Exosomes: Their role in pathogenesis, diagnosis and treatment of diseases
Cancers, Vol. 13, Núm. 1, pp. 1-45
-
Improved functionality of integration-deficient lentiviral vectors (IDLVs) by the inclusion of IS2 protein docks
Pharmaceutics, Vol. 13, Núm. 8
2020
-
Development of Cellular Models to Study Efficiency and Safety of Gene Edition by Homologous Directed Recombination Using the CRISPR/Cas9 System
Cells, Vol. 9, Núm. 6
-
Exosome: A new player in translational nanomedicine
Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-27
-
Externally-Controlled Systems for Immunotherapy: From Bench to Bedside
Frontiers in Immunology, Vol. 11
-
Genome-edited adult stem cells: Next-generation advanced therapy medicinal products
Stem Cells Translational Medicine, Vol. 9, Núm. 6, pp. 674-685
-
Proceedings From the First International Workshop at Sidra Medicine: “Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development”, 15th–16th February 2019, Doha, Qatar
Frontiers in Immunology, Vol. 11
-
Using Gene Editing Approaches to Fine-Tune the Immune System
Frontiers in Immunology, Vol. 11
2019
-
Stable genetic modification of mesenchymal stromal cells using lentiviral vectors
Methods in Molecular Biology (Humana Press Inc.), pp. 267-280
2018
-
Comparison of Zinc Finger Nucleases Versus CRISPR-Specific Nucleases for Genome Editing of the Wiskott-Aldrich Syndrome Locus
Human Gene Therapy, Vol. 29, Núm. 3, pp. 366-380
-
The IS2 Element Improves Transcription Efficiency of Integration-Deficient Lentiviral Vector Episomes
Molecular Therapy - Nucleic Acids, Vol. 13, pp. 16-28
2017
-
Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosis
British Journal of Pharmacology, Vol. 174, Núm. 3, pp. 238-253
2016
-
Absence of WASp enhances hematopoietic and megakaryocytic differentiation in a human embryonic stem cell model
Molecular Therapy, Vol. 24, Núm. 2, pp. 342-353
-
Biased and unbiased methods for the detection of off-target cleavage by CRISPR/Cas9: An overview
International Journal of Molecular Sciences, Vol. 17, Núm. 9